Helen Krol
Nurse Practitioner · Meriden, CTNPI 1265281935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$752
- Ardelyx, Inc.$643
- Madrigal Pharmaceuticals$421
- Gilead$391
- Takeda Pharmaceuticals U.S.A., Inc.$365
- Phathom Pharmaceuticals, Inc.$307
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,34098%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $752 |
| Ardelyx, Inc. | 30 | $643 |
| Madrigal Pharmaceuticals | 11 | $421 |
| Gilead | 23 | $391 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $365 |
| Phathom Pharmaceuticals, Inc. | 18 | $307 |
| Johnson & Johnson(2 entities) | 10 | $294 |
| Lilly USA, LLC | 10 | $183 |
| Ironwood Pharmaceuticals, Inc | 8 | $181 |
| Pfizer | 12 | $158 |
| Amgen | 4 | $121 |
| Novo Nordisk | 4 | $91 |
| Celltrion USA Inc. | 3 | $82 |
| Intercept Pharmaceuticals, Inc. | 3 | $75 |
| Exact Sciences | 3 | $72 |
| QOL Medical, LLC | 2 | $64 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Bristol Myers Squibb | 2 | $50 |
| Braintree Laboratories, Inc. | 2 | $37 |
| Digestive Care, Inc. | 1 | $33 |
| Organon | 1 | $24 |
| Biocon Biologics Inc | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,435 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 26 | $1,624 |
| Famotidine | 13 | $107 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Meriden
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
- Paul FidrychNorwich$23K
- Priscilla QuilterNorwich$21K
- Kimberly BoldonMiddletown$19K
- Emma RobinsonStamford$17K
- Janice TavaresBridgeport$17K
- Kelly WilberWaterbury$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.